According to the latest report by IMARC Group, titled “Oxygen Therapy Market Report: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026″, the global oxygen therapy market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the global oxygen therapy market to grow at a CAGR of around 10% during 2021-2026.
Oxygen therapy, also known as supplemental oxygen, refers to a medical treatment wherein an additional oxygen source is utilized. It finds extensive application during medical conditions, such as chronic obstructive pulmonary diseases, pneumonia, asthma, cystic fibrosis, and others,which leads to low blood oxygen levels. Nowadays, oxygen therapy is provided via nose tubes or cannulas, masks, or tents worldwide.
Request Free Sample Report: https://www.imarcgroup.com/oxygen-therapy-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally-our estimates about the latest market trends and forecast values after considering the impact of this pandemic.
Global Oxygen Therapy Market Trends:
A considerable rise in the prevalence of respiratory disorders among individuals represents one of the major factors creating a positive market outlook. Apart from this, due to the rising geriatric population and the growing consumption of nicotine and tobacco products, there is an increase in the demand for oxygen therapy around the world. Furthermore, the key players are developing cost-effective and accurate oxygen therapy devices to expand their product portfolio. This, in confluence with the growing traction of oxygen therapy among physicians, doctors, surgeons and patients, is driving the market.
Key Market Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Allied Healthcare Products Inc.
- Becton Dickinson and Company
- DeVilbiss Healthcare LLC (Drive Medical Inc.)
- Fisher & Paykel Healthcare Limited
- General Electric Company
- Getinge AB
- Hersill SL
- Invacare Corporation
- Koninklijke Philips N.V
- Smiths Group plc
- Tecno-Gaz S.p.A.
- Teleflex Incorporated
Breakup by Product:
- Oxygen Source Equipment
- Oxygen Cylinders
- Oxygen Concentrators
- Liquid Oxygen Devices
- PAP Devices
- Oxygen Delivery Devices
- Oxygen Masks
- Nasal Cannula
- Venturi Masks
- Non-rebreather Masks
- Bag Valve Masks
- CPAP Masks
- Others
Breakup by Application:
- Chronic Obstructive Pulmonary Disease
- Asthma
- Obstructive Sleep Apnea
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Pneumonia
- Others
Breakup by End-Use:
- Home Healthcare
- Hospitals
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Key highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, Medical, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
